Latest Breaking News On - Michel lussier - Page 3 : comparemela.com

Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology SA: Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomMont saint guibertWaals gewestMichel lussierStefan klotterDavid georgesCompany or celyad oncologyExchange commissionRegulatory newsBelgian lawDouble voting rightChief executive officerCelyad oncologyPrivate securities litigation reform actAnnual reportLassen sie

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Celyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomMont saint guibertWaals gewestMichel lussierCompany or celyad oncologyExchange commissionBelgian lawDouble voting rightChief executive officerCelyad oncologyPrivate securities litigation reform actAnnual report

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)

Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United kingdomMont saint guibertWaals gewestMichel lussierDavid georgesCompany or celyad oncologyExchange commissionTotal numberVoting rightsBelgian lawDouble voting rightChief executive officerCelyad oncologyPrivate securities litigation reform actAnnual reportMedia contact

Celyad announces management change

Celyad announces management change
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMont saint guibertWaals gewestHilde windelsGeorges rawadiDavid georgesMichel lussierExchange commissionFriday decemberCelyad oncologyPrivate securities litigation reform actAnnual reportOncology investorMedia contact

Celyad Announces Management Change

MONT-SAINT-GUIBERT, Belgium, December 04, 2023 Regulatory News: Celyad Oncology (Euronext: CYAD) (Brussels:CYAD) (Paris:CYAD) (NASDAQ:CYAD), a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells announces that its CEO and managing director Georges Rawadi has decided to step down, effective as of Friday December 1, 2023.

Bruxelles capitaleMont saint guibertWaals gewestFrance generalNew yorkUnited statesHilde windelsMichel lussierDavid georgesGeorges rawadiExchange commissionRegulatory newsFriday decemberCelyad oncologyPrivate securities litigation reform actAnnual report